Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041032 | SCV000064723 | benign | not specified | 2012-09-19 | criteria provided, single submitter | clinical testing | Ser4623Ser in exon 45A of TTN: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and has been identifie d in 5.1% (224/4384) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs7 2648906). |
Gene |
RCV000041032 | SCV000169559 | benign | not specified | 2014-01-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV001528308 | SCV001471070 | benign | not provided | 2023-09-28 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001528308 | SCV005241366 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV001528308 | SCV001739830 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000041032 | SCV001924795 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000041032 | SCV001952239 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004537133 | SCV004734505 | benign | TTN-related disorder | 2019-03-12 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |